Abstract:Supplementary Figures S1-S15. Identification and enrichment of CSCs directly from clinical SCCHN samples ; qRT-PCR measurement of the c-Met mRNA level and western blot measurement of c-Met protein in HN-CSC#1 spheres, HN-CSC#2 spheres, and HN-CSC#3 spheres infected with lentiviral nonspecific shRNA (scramble) or c-Met-specific shRNAs ; Knockdown of c-Met inhibited the properties of HN-CSCs ; Dose-dependent effect of conventional chemotherapeutic agents (cisplatin, 5-Fu, and docetaxel) on the viability of tumor cells derived from patient HN-0-22, HN-0-29, or HN-0-46 ; Treatment with c-Met inhibitor PF-2341066 inhibited the formation of HN-CSC#2 spheres and HN-CSC#3 spheres in a dose-dependent manner ; Treatment with c-Met inhibitor SU11274 inhibited the formation of HN-CSC#1 spheres and HN-CSC#2 spheres in a dose-dependent manner ; The combination of c-Met inhibition and docetaxel treatment eliminates CSCs in patient-derived tumor xenografts ; Pharmacologic inhibition of c-Met enhances the therapeutic efficacy of conventional anti-cancer agent 5-Fu ; Western blot analysis shows that no anaplastic lymphoma kinase (ALK) expression was detected in seven SCCHN PDXs including HN-0-22, HN-0-29, and HN-0-46-derived xenografts ; Histologic confirmation of metastasis by H&E staining ; RT2 Profiler PCR Array and further qPCR validation ; Downregulation of FZD8-mediated Wnt/β-catenin signaling is a crucial step for the elimination of HN-CSCs caused by c-Met inhibition ; Quantification of the normalized photon flux, measured at weekly intervals following cells inoculation ; Western blot analyses ; C-Met functionally regulates FZD8 through an ERK/c-Fos cascade in HN-CSCs .

Supplementary Methods and References from Targeting the C-Met/fzd8 Signaling Axis Eliminates Patient-Derived Cancer Stem–like Cells in Head and Neck Squamous Carcinomas

Supplementary Methods and References from MEF2D Transduces Microenvironment Stimuli to ZEB1 to Promote Epithelial–Mesenchymal Transition and Metastasis in Colorectal Cancer

Supplementary Data from Tumor-Derived Small Extracellular Vesicles Inhibit the Efficacy of CAR T Cells against Solid Tumors

Supplementary Tables S1-S8 from Targeting the c-Met/FZD8 Signaling Axis Eliminates Patient-Derived Cancer Stem–like Cells in Head and Neck Squamous Carcinomas

Supplementary Methods from Intracrine VEGF Signaling Mediates the Activity of Prosurvival Pathways in Human Colorectal Cancer Cells

Biomarkers Of Head And Neck Cancer Stem Cells And Targeted Therapeutic Strategies

Supplementary Methods from MEK Inhibition Modulates Cytokine Response to Mediate Therapeutic Efficacy in Lung Cancer

Targeting the C-Met/fzd8 Signaling Axis Eliminates Patient-Derived Cancer Stem-Like Cells in Head and Neck Squamous Carcinomas.

Supplementary Figures S1-S15 from Targeting the C-Met/fzd8 Signaling Axis Eliminates Patient-Derived Cancer Stem–like Cells in Head and Neck Squamous Carcinomas

Supplementary Materials and Methods from Serglycin is a Theranostic Target in Nasopharyngeal Carcinoma That Promotes Metastasis

Supplementary Methods, Figures 1-4 from Rho Kinase Phosphorylation Promotes Ezrin-Mediated Metastasis in Hepatocellular Carcinoma

Supplementary Figures and Tables from Preclinical Characterization of XL092, a Novel Receptor Tyrosine Kinase Inhibitor of MET, VEGFR2, AXL, and MER

Supplementary Table S3 from A 5-Hydroxymethylcytosine-Based Noninvasive Model for Early Detection of Colorectal Carcinomas and Advanced Adenomas: The METHOD-2 Study

Supplementary Methods from Tracking and Functional Characterization of Epithelial–Mesenchymal Transition and Mesenchymal Tumor Cells During Prostate Cancer Metastasis

Supplementary Methods from an Integrated Genome-Wide Approach to Discover Tumor-Specific Antigens As Potential Immunologic and Clinical Targets in Cancer

Supplementary materials and methods from Repolarization of Immunosuppressive Macrophages by Targeting SLAMF7-Regulated CCL2 Signaling Sensitizes Hepatocellular Carcinoma to Immunotherapy

Supplementary Methods from the CRTC1-NEDD9 Signaling Axis Mediates Lung Cancer Progression Caused by LKB1 Loss

Supplementary Methods, Tables 1 - 2, Figure Legend from Targeting Blockage of STAT3 in Hepatocellular Carcinoma Cells Augments NK Cell Functions Via Reverse Hepatocellular Carcinoma–Induced Immune Suppression

Supplementary Materials and Methods from C8orf76 Promotes Gastric Tumorigenicity and Metastasis by Directly Inducing Lncrna DUSP5P1 and Associates with Patient Outcomes

Supplementary Tables from Repolarization of Immunosuppressive Macrophages by Targeting SLAMF7-Regulated CCL2 Signaling Sensitizes Hepatocellular Carcinoma to Immunotherapy